Results 171 to 180 of about 43,423 (294)

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report. [PDF]

Front Immunol
Jedynak-Wąsowicz U, Klim L, Cichocka-Jarosz E.   +2 more
europepmc   +1 more source

Candida oesophagitis as an Initial Manifestation of VEXAS Syndrome: Expanding Evidence for an Acquired Immunodeficiency Phenotype

eJHaem, Volume 7, Issue 4, August 2026.
Demi Rianne Vintges, Marina Weerheim, Faiz Karim   +2 more
wiley   +1 more source

From Inflammatory Bowel Disease to Cancer: Gut Microbiota–Immune Microenvironment Crosstalk and Natural Product‐Based Therapeutic Opportunities

Cancer Nexus, Volume 2, Issue 3, July 2026.
ABSTRACT Inflammatory bowel disease (IBD), primarily Crohn's disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract and an important risk factor for IBD‐associated cancer. Increasing evidence suggests that gut microbiota dysbiosis, epithelial barrier dysfunction, and immune microenvironment remodeling
Xue Zhang, Chongchong Gao, Rui Jiang, Zijian Wu, Jian Bai   +4 more
wiley   +1 more source

Candida esophagitis complicated by esophageal stricture [PDF]

Endoscopy, 2010
J J, Hyun, H J, Chun, B, Keum, Y S, Seo, Y S, Kim, Y T, Jeen, H S, Lee, S H, Um, C D, Kim, H S, Ryu   +9 more
openaire   +2 more sources

A phase 3, randomized clinical trial of soticlestat as adjunctive therapy for Lennox–Gastaut syndrome

Epilepsia, Volume 67, Issue 7, Page 3420-3431, July 2026.
Soticlestat as adjunctive therapy for Lennox–Gastaut syndrome. Abstract Objective There remains a need for new treatments for Lennox–Gastaut syndrome (LGS), a developmental and epileptic encephalopathy with a heterogenous patient population that often requires polytherapy. The phase 3, randomized SKYWAY study (NCT04938427) investigated the efficacy and
Renzo Guerrini, Eric D. Marsh, Wei‐Ping Liao, Katsumi Imai, Ruzica Kravljanac, Anna Altmann, Cecil D. Hahn, Stéphane Auvin, Jimmy Schiemann, Yasir Khan, Pranab Mitra, Sarah I. Sheikh, Philipp von Rosenstiel, Mahnaz Asgharnejad, Dennis Dlugos, Venkatesha Murthy   +15 more
wiley   +1 more source

Herpes Simply Strikes Back: A Case of Recurrent Esophagitis in an Immunocompetent Patient. [PDF]

Cureus
Youssef MY, Brestel A, Khan H, Usman A, John J.   +4 more
europepmc   +1 more source

Bioactivity Assessment and In Silico Target Engagement of Clerodendrum infortunatum Extracts: Correlating Experimental Outcomes With DFT and Docking Predictions

Food Science &Nutrition, Volume 14, Issue 7, July 2026.
Clerodendrum infortunatum (Lamiaceae) is widely used in traditional medicine across South and Southeast Asia for the treatment of inflammation, fever, pain, and gastrointestinal disorders, yet its pharmacological efficacy and phytochemical basis remain inadequately validated by scientific research.
Mohi Uddin, Sabikun Naher, Md. Hossain Rasel, Md. Jahirul Islam Mamun, Md. Nazmul Hasan, Nazmul Hasan Eshaque, Md. Mahmudul Hasan   +6 more
wiley   +1 more source

From body composition to reflux esophagitis: an interpretable machine learning model based on CT-derived features. [PDF]

Front Physiol
Wang T, Chen L, Li Y, Zhang Q, Ou X, Lu Q.   +5 more
europepmc   +1 more source

DRIVE v3: Command Line Application for Identity‐by‐Descent Haplotype Clustering in Large Biobank Scale Data

Genetic Epidemiology, Volume 50, Issue 5, July 2026.
ABSTRACT There is a need for genetic analytical methods that integrate multi‐individual identity‐by‐descent (IBD) tools with phenotypic enrichment testing to discover novel shared haplotypes contributing to disease traits. Existing tools are designed to identify IBD sharing and leave interpretation and phenotype association tests to further analyses ...
James T. Baker, Hung‐Hsin Chen, Grahame F. Evans, Alyssa C. Scartozzi, Ryan J. Bohlender, Chad D. Huff, Quinn S. Wells, David C. Samuels, Jennifer E. Below   +8 more
wiley   +1 more source

Molecular and immunological heterogeneity of eosinophilic esophagitis: Insights and subtyping. [PDF]

PLoS One
Twum E, Baranova A, Ullah A.
europepmc   +1 more source